About CytoSite Biopharma

About company

CytoSite Biopharma is a biotechnology start-up developing a new technology to predict and monitor response to Immuno-Oncology therapy. The company develops a novel and proprietary small molecule PET imaging probe that will enable clinicians to predict early in the treatment cycle which patients will respond to I-O therapy. It was founded by James Jenson in 2016 and is based in Sudbury, Massachusetts.